SMER3 is a selective inhibitor of Skp1-Cullin-F-box ubiquitin ligase, regulating transcription, cell cycle, and immune response. It enhances rapamycin sensitivity and modulates methionine biosynthesis, offering potential applications in cancer research by targeting E3 ligase-driven tumorigenesis.
Usually ships within 24 hours.